Skip to main content
OpenTrials

Clinical trial condition

Metastatic/Advanced Renal Cell Carcinoma

Explore clinical trials studying Metastatic/Advanced Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Metastatic/Advanced Renal Cell Carcinoma trial results

Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

NCT07227415

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, +30 more
Locations
  • Mayo Clinic Building- Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 128 locations
View Trial Details
Completed

Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

NCT02187042

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • CHU de la Timone Marseille, Cedex 5, France
  • CHU Strasbourg Strasbourg, Cedex, France
  • Centre Hospitalier d'Annecy Annecy, France
  • Centre Catalan Urologie Andrologie Cabestany, France
View all 13 locations
View Trial Details

Related conditions